Skip to main content

Table 6 Repeated measures multivariate regression: effect of gender on EuroQol score

From: Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® In the Management of Asthma) study

 

Estimate

Standard Error

p-value

Intercept

0.820

0.071

< 0.0001

Gender (females vs males)

− 0.055

0.024

0.028

Visit (6-month follow up vs baseline)

0.093

0.015

< .0.0001

Visit (12-month follow up vs baseline)

0.099

0.015

< .0.0001

Age (years)

0.000

0.001

0.826

Comorbidities (no vs yes)

0.037

0.025

0.147

Smoke (current/former vs no smoker)

− 0.009

0.028

0.752

Asthma duration (years)

0.000

0.001

0.712

ICS (no vs yes)

− 0.026

0.029

0.382

ICS + LABA (no vs yes)

− 0.032

0.041

0.439

OCS (no vs yes)

0.039

0.036

0.278

Omalizumab total dose (mg)

0.000

0.003

0.510

Exacerbations in the 12 months before enrollment (0 vs ≥ 1)

0.052

0.063

0.409